We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BNR market cap is 0. The company's latest EPS is CNY and P/E is N/A.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 154.63M | 142.24M | 142.52M | 146.27M | 127.57M |
| Operating Income | -234.64M | -217.44M | -188.46M | -135.72M | -178.82M |
| Net Income | -231.48M | -216.23M | -185.25M | -131.24M | -174.98M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 208.87M | 381.68M | 429.9M | 507.86M | 563.24M |
| Operating Income | -161.4M | -169.09M | -412.41M | -797.06M | -980.41M |
| Net Income | -232.35M | -334.17M | -471.92M | -796.7M | -971.23M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 1.73B | 1.59B | 1.42B | 1.33B | 1.17B |
| Total Liabilities | 432.35M | 429.13M | 371.81M | 363.15M | 303.75M |
| Total Equity | 1.3B | 1.16B | 1.05B | 967.61M | 862.97M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 372.67M | 847.56M | 2.66B | 2.28B | 1.59B |
| Total Liabilities | 380.02M | 212.02M | 242.02M | 433.28M | 429.13M |
| Total Equity | -603.46M | -891.49M | 2.42B | 1.85B | 1.16B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -389.1M | -456.81M | -113.14M | -192.35M | -239.76M |
| Investing | -2.43M | -7.46M | -4.06M | -6.99M | -8.97M |
| Financing | -76.16M | -86.24M | -32k | -1.04M | -46.92M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -148.78M | -228.04M | -73.54M | -477.89M | -456.81M |
| Investing | 106.09M | -346.66M | -109.31M | 81.7M | -7.46M |
| Financing | 83.39M | 571.74M | 2.17B | -52.9M | -86.24M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (4.27%) |
| Company Name | Burning Rock Biotech Ltd |
| Address |
po box 309 grand cayman KY1 1104 |
| Website | https://www.brbiotech.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
